Simplifying Global Compliance
Articles Tagged with ''Daily International Pharma Alert''
Quality Chemicals, a pharmaceutical distributor in Uganda, has teamed up with Indian generic drugmaker Cipla, to build a manufacturing facility and produce HIV antiretrovirals (ARVs) in Uganda, according to the Kampala, Uganda-based newspaper The Monitor. Read More
Wyeth will respond this month to Form 483 observations from an FDA reinspection of the company's Guayama, Puerto Rico, manufacturing facility, the firm announced. Read More
Dutch biotech company Crucell announced it had received a grant from the European Commission for the development of a pandemic influenza vaccine. Read More
The Australian Therapeutic Goods Administration (TGA) has asked sanofi-aventis to add an alcohol use contraindication to the labeling of its insomnia drug Stilnox in response to recent reports of unusual sleep behaviors, the company announced. Read More
Aspen Pharmacare and Tibotec Pharmaceuticals announced they have signed a royalty-free, nonexclusive license agreement under which Aspen will develop and distribute the HIV drug Prezista in Sub-Saharan Africa. Read More
Canada's Therapeutic Products Directorate has approved two generic drugs manufactured by Orchid Chemicals & Pharmaceuticals, the company announced. Read More
As part of its market study into exclusive pharmaceutical distribution contracts, the UK's Office of Fair Trading (OFT) could launch an investigation into Pfizer's wholesale distribution contract with Unichem. Read More
The recently announced free-trade agreement (FTA) between South Korea and the U.S. will improve the pharmaceutical market in Korea, according to a statement by the Pharmaceutical Research and Manufacturers of America (PhRMA). Read More
Afro Alpine Pharma has started manufacturing artemisinin, which is used to make malaria drugs, at a newly opened $4 million facility in Kabale, Uganda, according to the Kampala-based newspaper New Vision. Read More
Bristol-Myers Squibb (BMS) is cooperating with U.S. trade officials in a new civil probe launched last week related to the patent litigation settlement over generic Plavix, the company said. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing